SHINEWAY PHARM released its interim results, with a profit of 615 million yuan, a year-on-year decrease of 1.89%
I'm PortAI, I can summarize articles.
SHINEWAY PHARM released its mid-term results for 2025, with revenue of 1.653 billion yuan, a year-on-year decrease of 20.8%; profit for the period was 615 million yuan, a year-on-year decrease of 1.89%. Basic earnings per share were 0.81 yuan, and an interim dividend of 0.11 yuan per share is proposed. The gross profit margin fell from 75.3% to 72.2%, mainly due to rising raw material costs. Despite the decline in sales and gross profit margin, net profit only slightly decreased by 1.9%, and the net profit margin rose to 37.2%. Oral products accounted for 65.8% of total sales
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments